Remove Biomarkers Remove Obesity Remove Patient Care
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patient care.

Education 100
article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

Libby made a poignant observation, emphasizing that his LDL goal for patients is “ALARA: As Low As Reasonably Achieved.” Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Aronne, MD , discussed advances in obesity pharmacology, while Virend K. Experts like Louis J.

CME 64